Browsed by
Tag: longevity

SENS Research Foundation Joins the Global #GivingTuesday Movement – Press Release by SENS Research Foundation

SENS Research Foundation Joins the Global #GivingTuesday Movement – Press Release by SENS Research Foundation

Comments 0 Comment
The New Renaissance Hat
SENS Research Foundation
November 28, 2015
******************************
Every Dollar Contributed Up to the First $5,000 Will Be Quadrupled, Turning into $20,000.
 ***

MOUNTAIN VIEW, Calif. — November 24, 2015 — The SENS Research Foundation (SRF), a non-profit organization focused on transforming the way the world researches and treats age-related disease, has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and celebrate generosity worldwide. Every dollar donated to SRF up to the first $5,000 will be quadrupled, making every dollar raised turn into $20,000.

Occurring this year on December 1, #GivingTuesday is held annually on the Tuesday after Thanksgiving (in the U.S.) and the widely recognized shopping events Black Friday and Cyber Monday to kick-off the holiday giving season and inspire people to collaborate in improving their local communities and to give back in impactful ways to the charities and causes they support.

SENS Research Foundation is aiming to reach a goal of $20,000 with the help of contributors who have pledged to match each dollar raised up to the first $5,000. The Croeni Foundation, a philanthropic organization dedicated to giving, the environment and health, has pledged to match the first $5,000 raised dollar for dollar. The foundation gave SRF an unrestricted $5,000 earlier this year, as well. Aubrey de Grey, CSO of SENS Research Foundation, has offered a dollar for dollar matching challenge up to $5,000. And Fight Aging! will match every dollar up to $125,000 through December 31, 2015. Fight Aging! encourages the development of medical technologies, lifestyles, and other means to help people live comfortably, healthily, and capably for as long as they desire.

“We are looking forward to participating in #GivingTuesday for a second year, and offer our thanks to Jan Croeni and the Croeni Foundation, as well as Aubrey de Grey and Fight Aging! for their support,” said Jerri Barrett, vice president of outreach, SENS Research Foundation. “Today’s cost for the treatment and care of chronic diseases of aging costs around $40,000 per second and will only continue to go up, as we spend more money per patient, while the number of patients is increasing. As a society, we need to change our ways and start treating age-related diseases more intelligently. The funds we raise on #GivingTuesday will help facilitate our efforts to do just that, as we work to continue learning how to prevent or reverse age-related diseases.”

Those who are interested in joining SENS Research Foundation’s #GivingTuesday initiative can donate at www.sens.org/donate. To learn more about #GivingTuesday participants and activities or to join the celebration of giving, please visit: http://www.givingtuesday.org/

About SENS Research Foundation (SRF)

SENS Research Foundation is a 501(c)(3) nonprofit that works to research, develop, and promote comprehensive regenerative medicine solutions for the diseases of aging. SRF is focused on a damage repair paradigm for treating the diseases of aging, which it advances through scientific research, advocacy, and education. SENS Research Foundation supports research projects at universities and institutes around the world with the goal of curing such age-related diseases as heart disease, cancer, diabetes and Alzheimer’s disease. Educating the public and training researchers to support a growing regenerative medicine field are also major endeavors of the organization that are being accomplished though advocacy campaigns and educational programs. For more information, visit www.sens.org.

Media Contact:
Jerri Barrett
408-204-7229
jerri.barrett@sens.org

The Immortals Among Us – Article by Reason

The Immortals Among Us – Article by Reason

Comments 1 comment
The New Renaissance Hat
Reason
November 26, 2015
******************************

Let us define immortality as being a state of agelessness, which seems a common colloquial usage these days. More precisely this means that the risk of death due to intrinsic causes such as wear and tear damage of vital organs remains the same over time, perhaps due to advanced medical interventions. Falling pianos are still going to kill you, and a hypothetical biologically young immortal in a hypothetical environment maintaining today’s first world extrinsic mortality rate would have a half-life of 500 years or so, meaning that at any age, there is a 50% chance of evading a life-ending event for another 500 years. There are no human immortals by this criteria of a static intrinsic mortality rate, it seems, though for a while it looked like very old humans might have essentially flat but very high mortality rates in the same way as very old flies do. Immortality in a state of advanced frailty and coupled with a 90% or higher yearly mortality rate isn’t the sort of circumstance that most people would aspire to, of course. It barely improves on the actual circumstance that the oldest of people find themselves in, all too briefly.

However, let us think beyond the box. Consider the small horde of children that you’ll find playing and running in any junior schoolyard here and now. By the time the survivors of their cohorts reach a century of age, the 2100s will have arrived. If the current very slow trend in increasing adult life expectancy continues, adding a year of remaining life expectancy at 60 for every passing decade, then something like 25% of these present children will live to see that centenary. But I don’t for one moment believe that this trend will continue as it has in the past. Past increases in life expectancy were an incidental side-effect of general improvements in medicine across the board, coupled with increasing wealth and all the benefits that brings. Across all of that time, no-one was seriously trying to intervene in the aging process, to address the causes of aging, or to bring aging under medical control. Times are changing, and now many groups aiming to build some of the foundations needed to create exactly this outcome. You may even have donated to support some of them, such as the SENS Research Foundation. The trend in longevity in an age in which researchers are trying to treat the causes of aging will be very different from the trend in longevity in an age in which no such efforts are taking place.

You don’t have to dig very far into the state of the science to see that the first rejuvenation treatments are very close, their advent limited only by funding. If funding were no issue for senescent cell clearance, for example, it would absolutely, definitively be in clinics a decade from now. Other necessary technologies are more distant, but not that much more distant – the 2030s will be an exciting time for the medical sciences. For the occupants of today’s junior playground, it seems foolish to imagine that by age 60 they will not have access to rejuvenation treatments after the SENS model at various stages of maturity, many having having been refined for more than 30 years, at the height of their technology cycle, and just giving way to whatever radical new improvement happens next.

Take a moment for a sober look at the sweeping differences and expanded technological capabilities that exist between today, the 1960s, and the 1910s. So very much has been achieved, and that pace of progress is accelerating. Those junior playground athletes of today will live to see a world even more radically different and advanced than our present time is in comparison to the First World War era. These are the immortals among us. The majority of them will have the opportunity to attain actuarial escape velocity, to keep on using ever-improving versions of rejuvenation treatments until they are gaining life expectancy at a faster rate than they are aging. Their cellular damage, the wear and tear created by the normal operation of metabolism, will be repaired as fast as it is is generated. It is the rest of us, those of us who are no longer spring chickens, who are faced with much more of a race to the goal. The degree to which we can successfully fund and advocate the necessary research is the determinant of whether we can scrape by into the age of rejuvenation treatments, or whether we will gain modest benefits but still age to death – because we were born too soon, and because the rest of the world didn’t get its collective act together rapidly enough in what is now the very tractable matter of building a cure for aging.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries. 
***

This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.

Google Life Sciences to Fund Heart Disease Program – Article by Reason

Google Life Sciences to Fund Heart Disease Program – Article by Reason

Comments 0 Comment
The New Renaissance Hat
Reason
November 22, 2015
******************************

An interesting next step from Google Life Sciences: they are putting forward $50 million in search of a laboratory to propose a program that pushes forward the state of the art in research and treatment of heart disease. Spent over ten years, that would produce an organization about the present size of the SENS Research Foundation, or a tenth of the Buck Institute, for purposes of comparison – and smaller than many of the research groups presently dedicated to the study of heart disease. So this is a sizable and welcome investment in medical research, but the significance is overhyped by the reporting organization here; no-one is going to cure heart disease with a $50 million project, since heart disease is caused by aging, and in the most general sense. This is an effort to change the funding landscape, stir things up, and make some progress.

If you walk through the list of forms of cell and tissue damage that causes degenerative aging, near every one of them contributes to structural failure of the cardiovascular system. The loss of stem cell activity and consequent decline in repair of tissues is only one of these: oxidized lipids that contribute to atherosclerosis in blood vessel walls; extracellular cross-links stiffen blood vessel walls and cause hypertension and consequent structural weakening in the heart; senescent cells wreck havoc on all the tissues they accumulate in; transthyretin amyloids that accumulate with age are implicated in heart disease via their ability to clog the cardiovascular system; and the loss of lysosomal function in long-lived cells, including those of the heart, progressively damages their function. Curing heart disease, removing it from the picture, requires treatments that effectively address near all of the causes of aging.

Quote from “Google Aims a $50 Million Moonshot at Curing Heart Disease” by Davey Alba, WIRED, November 16, 2015:

Cardiovascular disease people on Earth than anything else – over 17 million a year, and the number keeps going up. Of those deaths, more than 40 percent is due to coronary heart disease. Medicine has drugs that can treat it and practices that can help prevent it, but nobody really knows what causes it or how to cure it. Now, Google and the American Heart Association aim to change that by dropping a $50 million funding bomb on the problem. And as you might expect from a Silicon Valley giant that believes in moving fast and breaking things – an approach that hasn’t always transferred well to basic scientific research – the company isn’t spreading the money around. Google Life Sciences and the AHA said the money would go to one team over five years. “Traditional research funding models are often incremental and piecemeal, making it difficult to study a long-term, multifaceted subject. AHA and Google Life Sciences have committed to a bold new approach.”

The AHA, already the largest funder of cardiovascular research in the US outside of the federal government, says the program will be its most heavily funded initiative in nearly a century. Applications begin in January and if all goes according to plan, they’ll be due by February 14th. (Valentine’s Day. Get it?) If you want the $50 million, your idea has to fit on a single page. And Google won’t take a financial or intellectual property stake in the results. The organizations hope that the program will accelerate the field of heart research much like Google’s self-driving car eventually compelled the entire automobile industry to follow its lead.

Link: http://www.wired.com/2015/11/google-aims-a-50-million-moonshot-at-curing-heart-disease/

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries. 
***

This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.

Lifespan Challenge: Support the MitoSENS Mitochondrial Repair Project Research Fundraiser – Video by G. Stolyarov II

Lifespan Challenge: Support the MitoSENS Mitochondrial Repair Project Research Fundraiser – Video by G. Stolyarov II

Comments 0 Comment
The New Renaissance HatG. Stolyarov II
October 21, 2015
******************************

Mr. Stolyarov, author of “Death is Wrong” and Chief Executive of the Nevada Transhumanist Party (NTP), challenges all members of the NTP and the general public to donate to life-extension research – particularly, the ongoing MitoSENS Mitochondrial Repair Project for which crowdfunding is currently being conducted on Lifespan.io.

LifespanChallengeSign-513x396

BioViva Treats First Patient with Gene Therapy to Reverse Aging – Press Release by Elizabeth Parrish

BioViva Treats First Patient with Gene Therapy to Reverse Aging – Press Release by Elizabeth Parrish

Comments 1 comment
The New Renaissance HatElizabeth Parrish
October 3, 2015
******************************

Seattle, WA – (PRWEB) – September 30, 2015

BioViva USA, Inc. has become the first company to treat a person with gene therapy to reverse biological aging, using a combination of two therapies developed and applied outside the United States of America. Testing and research on these therapies is continuing in BioViva’s affiliated labs worldwide.

BioViva CEO Elizabeth Parrish announced that the subject is doing well and has resumed regular activities. Preliminary results will be evaluated at 5 and 8 months with full outcome expected at 12 months. The patient will then be monitored every year for 8 years.

Gene therapy allows doctors to treat disease at the cellular level by inserting a gene into a patient’s cells instead of using the regular modalities of oral drugs or surgery. BioViva is testing several approaches to age reversal, including using gene therapy to introduce genes into the body.

Although not generally considered a disease, cellular aging is the leading cause of death in the developed world. Side effects like muscle wasting (sarcopenia), grey hair and memory loss are the well-known hallmarks.

And the aging cell is also responsible for the diseases of aging, including Alzheimer’s disease, heart disease and cancer. BioViva is leading the charge to treat the aging cell and reverse aging. “The aging cell is a key factor that has been overlooked for too long. Companies have put millions of dollars into treating the diseases of aging, such as dementia, frailty, kidney failure and Parkinson’s disease, and we still do not have a cure,” says Parrish.

Until now, no company had tried multiple gene therapies in one person. When asked why BioViva has done so, Parrish says, “Aging involves multiple pathways. We wanted to target more than one for a better outcome.”

Contact
Elizabeth Parrish
lparrish(at)BioVivaSciences(dot)com
http://www.biovivasciences.com

Elizabeth Parrish, CEO of BioViva, is a humanitarian, entrepreneur, and innovator, and is a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for Mensa-based, highly gifted persons who advance scientific discourse and discovery.

The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. Elizabeth is the founder of BioTrove Investments LLC and the BioTrove Podcasts, which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine.  She is also the Secretary of The American Longevity Alliance (ALA), a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular and regenerative medicine.

Editor’s Note: Elizabeth Parrish also made the announcement of this promising human trial at the October 1, 2015, Movement for Indefinite Life Extension (MILE) panel discussion “How Can Life Extension Become as Popular as the War on Cancer?” Watch the discussion here.

~ Gennady Stolyarov II, Editor-in-Chief, The Rational Argumentator, October 3, 2015

How Can Life Extension Become as Popular as the War on Cancer? – MILE Panel

How Can Life Extension Become as Popular as the War on Cancer? – MILE Panel

Comments 0 Comment

MILE-Demonstration-2-Ad

What can be done to raise public support for the pursuit of indefinite life extension through medicine and biotechnology to the same level as currently exists for disease-specific research efforts aimed at cancers, heart disease, ALS, and similar large-scale nemeses?

In this panel discussion, which occurred on October 1, 2015 – International Longevity Day – Mr. Stolyarov asks notable life-extension supporters to provide input on this vital question and related areas relevant to accelerating the pursuit of indefinite longevity. Watch the full discussion here.

This panel is coordinated in conjunction with MILE, the Movement for Indefinite Life Extension.

View the presentation slides prepared by Sven Bulterjis, “Aging Research Needs Marketing: What Can We Learn from Cancer Research?”:

***

Also see a statement prepared by Peter Rothman for this event. This statement was read out by Mr. Stolyarov during the panel, and panelists’ responses were solicited.

Read the announcement by Keith Comito – “The #LifespanChallenge Starting on October 1 – International Longevity Day”.

See Mr. Comito’s introductory video for the Lifespan Challenge.

*

Panelists

Adam Alonzi is the author of the fiction books “Praying for Death: A Zombie Apocalypse“and “A Plank in Reason”. He is also a futurist, inventor, DIY enthusiast, biotechnologist, programmer, molecular gastronomist, consummate dilletante and columnist at The Indian Economist. Listen to his podcasts at http://adamalonzi.libsyn.com/. Read his blog at https://adamalonzi.wordpress.com/.

Sven Bulterjis is a founder and member of the Board of Directors of Heales – the Healthy Life Extension Society, based in Brussels, Belgium. He has worked as a post-graduate researcher at the SENS Research Foundation and at Yale University. Moreover, he is an Advisor for the Lifeboat Foundation’s A-Prize, whose purpose is to put the development of artificial life forms into the open.

Keith Comito is a computer programmer and mathematician whose work brings together a variety of disciplines to provoke thought and promote social change. He has created video games, bioinformatics programs, musical applications, and biotechnology projects featured in Forbes and NPR.

In addition to developing high-profile mobile applications such as HBO Now and MLB AtBat, he explores the intersection of technology and biology at the Brooklyn community lab Genspace where he helped to create games which allow players to direct the motion of microscopic organisms. Read his Forbes article “Biological Games“.

Seeing age-related disease as one of the most profound problems facing humanity, he now works to accelerate and democratize longevity research efforts through initiatives such as Lifespan.io.
He earned a B.S. in Mathematics, B.S. in Computer science, and M.S. in Applied Mathematics at Hofstra University, where his work included analysis of the LMNA protein.

Roen Horn is a philosopher and lecturer on the importance of trying to live forever. He founded the Eternal Life Fan Club in 2012 to encourage fans of eternal life to start being more strategic with regard to this goal. To this end, one major focus of the club has been on life-extension techniques, everything from lengthening telomeres to avoiding risky behaviors. Currently, Roen’s work may be seen in the many memes, quotes, essays, and video blogs that he has created for those who are exploring their own thoughts on this, or who want to share and promote the same things. Like many other fans of eternal life, Roen is in love with life, and is very inspired by the world around him and wants to impart in others the same desire to discover all this world has to offer.

B.J. Murphy is the Editor and Social Media Manager of Serious Wonder. He is a futurist, philosopher, activist, author and poet. B.J. is an Advisory Board Member for the NGO nonprofit Lifeboat Foundation and a writer for the Institute for Ethics and Emerging Technologies (IEET).

Elizabeth Parrish, CEO of BioViva, is a humanitarian, entrepreneur, and innovator, and is a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for Mensa-based, highly gifted persons who advance scientific discourse and discovery.

The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. Elizabeth is the founder of BioTrove Investments LLC and the BioTrove Podcasts, which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine.  She is also the Secretary of The American Longevity Alliance (ALA), a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular and regenerative medicine.

Statement by Peter Rothman on the Question “How Can Life Extension Become as Popular as the War on Cancer?”

Statement by Peter Rothman on the Question “How Can Life Extension Become as Popular as the War on Cancer?”

Comments 1 comment
The New Renaissance HatPeter Rothman
October 1, 2015
******************************
Editor’s Note: This statement was prepared by Mr. Rothman in connection with the October 1, 2015, Movement for Indefinite Life Extension (MILE) Panel: “How Can Life Extension Become as Popular as the War on Cancer?” The panel took place from 11 a.m. to 1 p.m. US Pacific Time on October 1, 2015. This statement was read out by me during the panel, and panelists’ responses were solicited. Watch the recording of the discussion, including panelists’ responses to Mr. Rothman’s statement, here.
~ Gennady Stolyarov II, Editor-in-Chief, The Rational Argumentator, October 1, 2015
***
Question: “How Can Life Extension Become as Popular as the War on Cancer?”

I have a few thoughts on this question. Perhaps ironically, they’re in the form of more questions.

What exactly is the War on Cancer? How did it start?

How “popular” is it?

Does popularity in this sense correspond to funding, research results, or any meaningful metric?

Is this approach something we want to emulate?

***

Wikipedia reports, “The War on Cancer refers to the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by then U.S. President Richard Nixon is generally viewed as the beginning of the war on cancer, though it was not described as a “war” in the legislation itself.“

The War on Cancer is referring here to the passage of a law and is not really a war in the conventional sense.

The popularity of the idea is a bit of misleading thing. I’m not sure what this means here. How many people supported the law back when it was passed? How many people think it is a good idea now? How many people search for this phrase on Google? Popularity in the sense of the general public liking an idea had little or nothing to do with the passage of a law like this.

So in summary, the War on Cancer required the passage of a law allocating funds. The popularity of the idea had nothing to do with it.

The idea of war on a disease or an abstract concept such as “terror” is problematic. War suggests enemies to attack and weapons to deploy. But these metaphors are not always correct in reference to curing an illness like cancer or solving the complex problem of aging.

After all, the enemy in cancer is our own DNA. How can we attack it?

With aging the issue is even more dramatic. A war on aging suggests eliminating older persons perhaps. The war metaphor is at least overused and deserves to be questioned.

Has the war on cancer been won? Wars are won and lost, but our scientific investigation of methods to cure disease goes on. Just because a disease is able to be cured in some cases does not mean we have “won”.

Curing aging is in fact not entirely separate from curing cancer. Cancer is largely a disease of older persons, especially certain cancers. So any “war on aging” would at least overlap with the war on cancer. Creating a new war is always problematic, however.

Declaring war does not produce funding. Successfully defeating aging require funding of research and development of medical techniques, medicines, etc. It isn’t a PR campaign like “Say No to Drugs” during the Reagan era and the same methods of communication do not apply..

But transhumanists are notoriously bad at marketing, for example consider the failed Immortality Bus campaign which draws crowds of less than half a dozen people. Sure it is weird enough to get written up in Vice, but does it convince anyone that controls funding to support our efforts? Name one person or organization that has funded some scientific research as a result of this campaign. There isn’t one.

To move forward we have to focus on the efforts that matter, and that means getting research funding. A realistic approach to increasing research funding is forming a Political Action Committee to promote the idea in congress and in D.C. more generally. This is where the decision will be made as it was with Nixon’s 1971 Cancer Act. All other efforts are at best distractions, and at worst make our cause seem weird or out of the mainstream.

Weird, fringe causes do not attract funding.

In summary, I want to suggest to the panel and audience that they go All In for longevity research. This means doing whatever you can do yourself to achieve longevity. Eat right, get enough sleep. Avoid junk food. Exercise. Transhumanists that do not do these things are not in a good position to talk to the public about longevity at all in my view.

Beyond this, we need to directly support research ourselves. Crowdfunding is one avenue, but realistically crowdfunding is a drop in the bucket and will remain so when compared to the U.S. annual research budget of $65 billion dollars. Volunteer yourself.
***
References
https://en.wikipedia.org/wiki/War_on_Cancer
http://www.issues.org/19.4/updated/bailar.pdf
http://graylab.dfci.harvard.edu/assets/files/publication%20pdf/Review%20paper/Review-Haber%20DA-Cell-2011.pdf
http://timesofsandiego.com/opinion/2015/09/30/the-midlife-crisis-in-americas-war-on-cancer/
http://www.cell.com/cell/pdf/S0092-8674(15)00365-7.pdf
***

Peter Rothman, M.S. is Editor of H+ Magazine where he is looking for great articles about the future of technology, humanity, the mind, society, and human culture.

Peter is an engineering and management professional with deep experience in the design, development, and launch, of commercial software products, internet services, and other mission critical systems. He is currently doing research into analysis and visualization of text for a consumer facing application.

He was previously chief scientist of a biometrics-based fraud prevention company. He led the development of Live365.com, one of the largest providers of streaming audio on the Internet. He operated a product development and engineering team for the global multi-million dollar public software company MetaTools/MetaCreations. He founded and operated a startup software company, raised capital, and negotiated eventual sale of company. He has designed and implemented cutting-edge software, algorithms, and technologies.

Peter’s specialties include biometrics, mathematics, streaming media, virtual reality, simulation, text analysis, data visualization, and artificial intelligence.

Peter was an early developer of VR technologies, including developing applications of VR to financial visualization and a concept for unencumbered infantry training using VR for the US Army.

Aging Research Needs Marketing: What Can We Learn from Cancer Research? – Presentation by Sven Bulterjis

Aging Research Needs Marketing: What Can We Learn from Cancer Research? – Presentation by Sven Bulterjis

Comments 0 Comment
The New Renaissance HatSven Bulterjis
October 1, 2015
******************************
These presentation slides were prepared by Sven Bulterjis and are a component of the materials for the October 1, 2015, Movement for Indefinite Life Extension (MILE) Panel: “How Can Life Extension Become as Popular as the War on Cancer?” The panel took place from 11 a.m. to 1 p.m. US Pacific Time on October 1, 2015. Watch the recording of the discussion, including Mr. Bulterjis’s presentation, here.
***
***
Sven Bulterjis is a founder and member of the Board of Directors of Heales – the Healthy Life Extension Society, based in Brussels, Belgium. He has worked as a post-graduate researcher at the SENS Research Foundation and at Yale University. Moreover, he is an Advisor for the Lifeboat Foundation’s A-Prize, whose purpose is to put the development of artificial life forms into the open.
Longevity Alliance Contest Entry – Video by Adam Alonzi

Longevity Alliance Contest Entry – Video by Adam Alonzi

Comments 0 Comment
The New Renaissance Hat
Adam Alonzi
September 24, 2015
******************************

This is Adam Alonzi’s entry for a contest sponsored by the Longevity Alliance – http://longevityalliance.org. Narration, script, and video are by Adam Alonzi. The score is by Leslee Frost.

This video includes a reference to Death is Wrong, the children’s book on indefinite life extension. Find out more about Death is Wrong, and get free PDF downloads in four languages, here.

Adam Alonzi is the author of Praying for Death and A Plank in Reason. He is also a futurist, inventor, DIY enthusiast, biotechnologist, programmer, molecular gastronomist, consummate dilletante and columnist at The Indian Economist. Read his blog here. Listen to his podcasts at http://adamalonzi.libsyn.com.

Adam Alonzi’s Interviews
– Elizabeth Parrish – BioViva
– Alex Zhavoroknov – InSilico Medicine
– Maria Konovalenko – Science for Life Extension Foundation and Longevity Cookbook
– Luis Arana – Robots Without Borders

Nevada Transhumanist Party – Formation and Membership Invitation – Video by G. Stolyarov II

Nevada Transhumanist Party – Formation and Membership Invitation – Video by G. Stolyarov II

Comments 0 Comment
The New Renaissance HatG. Stolyarov II
September 22, 2015
******************************

Mr. Stolyarov introduces the Nevada Transhumanist Party, officially registered with the Nevada Secretary of State on August 31, 2015. All individuals who have a rational faculty and ability to form political opinions are welcome to become either Nevada Members or Allied Members.

Read the Constitution and Bylaws of the Nevada Transhumanist Party.

See the official filed documents with the Nevada Secretary of State.

Join the Nevada Transhumanist Party Facebook group: https://www.facebook.com/groups/NevadaTranshumanistParty/.

NTP-Logo-9-1-2015References

– Website of United States Transhumanist Party
– Zoltan Istvan’s Webpage
– Immortality Bus Website
– “The Transhumanist Wager” – Wikipedia
– “Thoughts on Zoltan Istvan’s The Transhumanist Wager: A Review” – Article by G. Stolyarov II